Phase II study of paclitaxel and epirubicin as first-line treatment in patients with metastatic nonsmall cell lung carcinoma

Giovanni L. Ceresoli, Stefania Dell'Oro, Paolo Passoni, Eugenio Villa

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Phase II study of paclitaxel and epirubicin as first-line treatment in patients with metastatic nonsmall cell lung carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences